Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Grimmer

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World SettingsRobert Perneczky, Niels Hansen, Anna Hofmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 26, 2011
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRIPanagiotis Alexopoulos, Christian Sorg, Annette Förschler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Metabolic connectivity mapping reveals effective connectivity in the resting human brainValentin Riedl, Lukas Utz, Gabriel Castrillón, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive ImpairmentTimo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
BMC Neurology|November 2, 2019
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
BMC Neurology|March 7, 2020
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2017
Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's DiseaseLorenzo Pasquini, Gloria Benson, Michel J Grothe, et al.
Neuro-Degenerative Diseases|July 3, 2019
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's DiseaseTimo Grimmer, Oliver Goldhardt, Igor Yakushev, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarwan N Sabbagh, Stephen Macfarlane, Audrey Gabelle, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2018
Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain VolumetryDennis M Hedderich, Judith E Spiro, Oliver Goldhardt, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World SettingsRobert Perneczky, Niels Hansen, Anna Hofmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 26, 2011
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRIPanagiotis Alexopoulos, Christian Sorg, Annette Förschler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Metabolic connectivity mapping reveals effective connectivity in the resting human brainValentin Riedl, Lukas Utz, Gabriel Castrillón, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive ImpairmentTimo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
BMC Neurology|November 2, 2019
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
BMC Neurology|March 7, 2020
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2017
Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's DiseaseLorenzo Pasquini, Gloria Benson, Michel J Grothe, et al.
Neuro-Degenerative Diseases|July 3, 2019
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's DiseaseTimo Grimmer, Oliver Goldhardt, Igor Yakushev, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarwan N Sabbagh, Stephen Macfarlane, Audrey Gabelle, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2018
Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain VolumetryDennis M Hedderich, Judith E Spiro, Oliver Goldhardt, et al.
Pageof 19